discontinuation risk ≥ 70%
Patients needing attention
Synthetic demo data
22
patients · discontinuation risk ≥ 70%
Most common reason
GI intolerance
Most effective previous action
GI-04
Nutritional protocol
Estimated addressable population
9
eligible for GI-04, confidence ≥ 70%
Predicted persistence gain
+17%
| Patient | Day | Baseline | GI | Tolerance | GI score | Discontinuation | Cluster |
|---|---|---|---|---|---|---|---|
| P-03323 | 148 | S14 | Unstable | Stable | 62 | 96% | EC-03 |
| P-03332 | 98 | S14 | Unstable | Stable | 77 | 96% | EC-03 |
| P-03341 | 142 | S14 | Unstable | Deteriorating | 71 | 96% | EC-03 |
| P-03345 | 145 | S14 | Unstable | Deteriorating | 73 | 96% | EC-03 |
| P-03390 | 138 | S14 | Unstable | Deteriorating | 70 | 96% | EC-03 |
| P-03413 | 150 | S14 | Unstable | Improving | 78 | 96% | EC-03 |
| P-03285 | 119 | S04 | Unstable | Deteriorating | 73 | 94% | LT |
| P-03430 | 121 | S14 | Unstable | Improving | 61 | 92% | EC-03 |
| P-03460 | 127 | S11 | Unstable | Deteriorating | 63 | 88% | EC-03 |
| P-03037 | 140 | S14 | Unstable | Stable | 66 | 87% | EC-03 |
| P-03145 | 139 | S14 | Deteriorating | Deteriorating | 57 | 87% | EC-03 |
| P-03030 | 147 | S14 | Unstable | Deteriorating | 66 | 82% | EC-03 |
| P-03120 | 109 | S14 | Unstable | Deteriorating | 61 | 81% | LT |
| P-03293 | 134 | S14 | Unstable | Deteriorating | 70 | 78% | EC-03 |
| P-03378 | 105 | S10 | Deteriorating | Deteriorating | 55 | 75% | LT |
| P-03049 | 139 | S14 | Unstable | Deteriorating | 59 | 74% | EC-03 |
| P-03099 | 148 | S17 | Unstable | Improving | 68 | 74% | LT |
| P-03365 | 93 | S14 | Improving | Improving | 42 | 74% | EC-03 |
| P-03070 | 147 | S14 | Deteriorating | Favorable | 55 | 73% | EC-03 |
| P-03251 | 110 | S14 | Unstable | Improving | 66 | 73% | EC-03 |
| P-03300 | 150 | S14 | Deteriorating | Favorable | 47 | 73% | EC-03 |
| P-03280 | 145 | S13 | Unstable | Deteriorating | 67 | 70% | LT |